ClinicalTrials.govpublic full text
CD20-CD19 Compound CAR (cCAR) T Cells for Patients With Relapsed /Refractory B Cell Malignancies
b cell lymphoma, b cell leukemia, cd20, cd19, ccar, leukemia, lymphoma, interventional, early_phase1
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 878848
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.